Sotatercept (mIgG2a)

Product Description: Sotatercept (mIgG2a) has direct cardioprotective actions, which reduces right ventricular (RV) remodeling and improves function in a pulmonary artery banding (PAB) mouse model[1].

Applications: Neuroscience-Neuromodulation

Formula: N/A

References: [1]Joshi S R, et al. Sotatercept Analog RAP-011 Inhibits Right Ventricular Remodeling and Restores Function in a Mouse Model of Pressure Overload. Circulation. 2020, 142(Suppl_3): A14397-A14397.

Molecular Weight: N/A

Compound Purity: 99.71

Research Area: Cardiovascular Disease

Solubility: 10 mM in DMSO

Target: Others

• Artikelnummer: MEXHY-P99590A-5
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99590A-5
• Verpackungseinheit: 5 mg
• Mengeneinheit: STK
• Konjugat: Unconjugated